EUVIMEDEUVIMED entdecken
Crossref

Aptazyme-directed A-to-I RNA editing

Xilei Ai, Zhuo Tang

Methods in Enzymology · 2025

DOI: 10.1016/bs.mie.2024.11.022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Methods in Enzymology, 2025. Verfasst von Xilei Ai und 1 weiteren Autor:innen. Beteiligte Einrichtung: Natural Products Research Center, Chengdu Institute of Biology, Chinese Academy of Science, Chengdu, P.R. China; Academy of Chinese Medical Sciences,…. Hauptthemen laut MEDLINE: RNA Editing, RNA, Adenosine Deaminase, RNA-Binding Proteins. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Sichuan Provincial Science and Technology Support Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As a promising therapeutic approach, the RNA editing process can correct pathogenic mutations and is reversible and tunable, without permanently altering the genome. RNA editing mediated by human ADAR proteins offers unique advantages, including high specificity and low immunogenicity. Compared to CRISPR-based gene editing techniques, RNA editing events are temporary, which can reduce the risk of long-term unintended side effects, making off-target edits less concerning than DNA-targeting methods. Moreover, ADAR-based RNA editing tools are less likely to elicit immune reactions because ADAR proteins are of human origin, and their small size makes them relatively easy to incorporate into gene therapy vectors, such as adeno-associated virus vectors (AAVs), which have limited space. Despite the promise of RNA editing as a therapeutic approach, precise temporal and spatial control of RNA editing is still lacking. Therefore, we have developed a small molecule-inducible RNA editing strategy by incorporating aptazymes into the guide RNA of the BoxB-λN-ADAR system. This chapter provides detailed protocols for targeted RNA editing by ADAR deaminases using aptazyme-based guide RNAs controlled by exogenous small molecules, marking the earliest use of aptazymes to regulate RNA editing strategies. Once small molecules are added or removed, aptazymes trigger self-cleavage to release the guide RNA, thus achieving small molecule-controlled RNA editing. To satisfy different RNA editing applications, we have realized the conditional activation and deactivation of A-to-I RNA editing of target mRNA using switch aptazymes. We provide step-by-step protocols for constructing guide RNA plasmids for regulatory purposes and conducting small molecule-induced RNA regulatory editing experiments in cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA EditingRNAAdenosine DeaminaseRNA-Binding ProteinsAnimalsAllosteric RegulationNucleic Acid Conformation

Stichwörter der Autor:innen

ADARAptazymesRNA editingRegulatorySmall molecules

Substanzen

RNAADAR protein, humanAdenosine DeaminaseRNA-Binding Proteins

Autor:innen und Institutionen

  • Natural Products Research Center, Chengdu Institute of Biology, Chinese Academy of Science, Chengdu, P.R. China; Academy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou, P.R. China.
  • Natural Products Research Center, Chengdu Institute of Biology, Chinese Academy of Science, Chengdu, P.R. China. Electronic address: tangzhuo@cib.ac.cn.

Förderung

  • Sichuan Provincial Science and Technology Support Program
  • National Natural Science Foundation of China

Zitieren

APA

Ai, X., & Tang, Z. (2025). Aptazyme-directed A-to-I RNA editing. Methods in Enzymology. https://doi.org/10.1016/bs.mie.2024.11.022

Vancouver

Ai X, Tang Z. Aptazyme-directed A-to-I RNA editing. Methods in Enzymology. 2025. doi:10.1016/bs.mie.2024.11.022

BibTeX
@article{Ai2025,
  author = {Ai, Xilei and Tang, Zhuo},
  title = {Aptazyme-directed A-to-I RNA editing},
  journal = {Methods in Enzymology},
  year = {2025},
  doi = {10.1016/bs.mie.2024.11.022}
}
Kostenlos starten →